Aptose Biosciences Inc - Company Profile
Powered by 
All the data and insights you need on Aptose Biosciences Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Aptose Biosciences Inc Strategy Report
- Understand Aptose Biosciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Aptose Biosciences Inc (Aptose) focuses on developing personalized therapies for the treatment of life-threatening cancers including, acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), certain B-cell malignancies and other hematologic malignancies. The company operates through one reportable segment which includes, discovery and development of personalized therapies addressing unmet medical needs in oncology.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D efforts focuses on developing high performance product candiates and incorporating active molecular biology technologies. In FY2022, Aptose spent US$28.1 million, which as a percentage of total revenue was 194.3% . The company having HM43239 product patents of 39 issued patents, including 3 US patents. Luxeptinib (CG-806) owning 46 issued patents, including 3 issued U.S. patents. The company has R&D facilities located in the Sandiego, California.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer